A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Condition(s):Frontotemporal Dementia; FTD; FTD-GRN; Dementia, FrontotemporalLast Updated:March 1, 2024Recruiting